Remission Medical Closes Series A Led by Blue Heron Capital to Expand Virtual Rheumatology Partnerships Across U.S. Health Systems

缓解医疗公司完成由蓝鹭资本领投的A轮融资，以扩大其在美国卫生系统中的虚拟风湿病学合作。

Investment accelerates the company's proven model of embedding specialty care directly inside health system operations, now active across major health system partners and backed by an AI-native workforce platform built to scale

投资加速了该公司经过验证的模式，即将专科护理直接嵌入卫生系统运营中，目前已在各大卫生系统合作伙伴中展开，并由一个旨在扩展的原生人工智能劳动力平台提供支持。

RICHMOND, Va., April 13, 2026-- Remission Medical, Inc., a virtual rheumatology company that contracts directly with health systems to deliver embedded specialty care, today announced the close of a Series A funding round led by Blue Heron Capital, an early-stage growth equity firm. The investment will fuel expansion of the company's partner network, grow its clinical workforce, and accelerate the scaling infrastructure that allows Remission Medical to rapidly deploy rheumatology access across more systems, more markets, and ultimately more specialties..

里士满，弗吉尼亚州，2026年4月13日——Remission Medical, Inc.是一家虚拟风湿病学公司，直接与卫生系统签订合同以提供嵌入式专科护理。该公司今天宣布，由早期增长股权公司Blue Heron Capital领投的A轮融资结束。这笔投资将推动公司合作伙伴网络的扩展，壮大其临床工作队伍，并加速扩展基础设施建设，使Remission Medical能够快速在更多系统、更多市场乃至更多专科领域部署风湿病学诊疗服务。

Rheumatic diseases, including rheumatoid arthritis, lupus, and psoriatic arthritis, affect more than 54 million Americans. Yet the United States faces a severe and worsening shortage of rheumatologists, leaving patients waiting an average of more than two months for a first specialist appointment. For health systems, this gap translates directly into lost referrals, declining quality scores, and patients who go undiagnosed or undertreated for conditions that are highly manageable when caught early..

风湿性疾病，包括类风湿性关节炎、狼疮和银屑病关节炎，影响着超过 5400 万美国人。然而，美国面临风湿病学家严重且日益加剧的短缺，导致患者平均需要等待两个多月才能预约到首次专科医生就诊。对于医疗系统而言，这一缺口直接导致转诊流失、质量评分下降，以及患者因未能早期发现而得不到诊断或治疗不足，而这些疾病在早期发现时是高度可管理的。

Remission Medical solves this through a turnkey partnership model. The company embeds highly credentialed Advanced Practice Providers (APPs) directly inside health system infrastructure, operating under existing EMR workflows, payer contracts, and clinical protocols, so health systems can stand up a functioning rheumatology service line in weeks rather than years.

Remission Medical 通过一站式合作模式解决了这一问题。该公司将资质极高的高级执业提供者（APP）直接嵌入医疗系统基础设施中，依托现有的电子病历工作流程、支付方合同和临床协议运作，从而使医疗系统能够在数周而非数年内建立一个功能齐全的风湿病服务线。

Critically, what enables Remission Medical to deploy this model at scale across a growing national network is RemissionOS (ROS), the company's proprietary AI-native workforce platform..

关键在于，使缓解医疗公司能够在全国不断扩大的网络中大规模部署这一模式的是该公司的专有人工智能原生劳动力平台——缓解操作系统（ROS）。

ROS is purpose-built to manage the complexity of running a distributed clinical workforce across multiple health system environments simultaneously. The platform supports how Remission Medical manages provider capacity, performance, and partner workflows at scale by automating referral intake, clinical scheduling, documentation support, revenue cycle operations, and performance reporting, all calibrated to each partner's existing EMR and operational protocols.

ROS 专为管理在多个医疗系统环境中同时运行的分布式临床工作团队的复杂性而构建。该平台支持 Remission Medical 通过自动化转诊接收、临床排班、文档支持、收入周期运营和绩效报告来大规模管理供应商能力、绩效及合作伙伴工作流程，所有这些都根据每个合作伙伴现有的电子病历（EMR）和操作协议进行校准。

This AI-native operational backbone allows Remission Medical to onboard new health system partners efficiently, maintain quality and consistency across a geographically dispersed provider network, and generate the outcomes data that health systems need to sustain and expand their rheumatology programs internally..

这一原生人工智能运营基础使Remission Medical能够高效吸纳新的卫生系统合作伙伴，在地理上分散的医疗服务提供商网络中保持质量和一致性，并生成卫生系统内部维持和扩展其风湿病学项目所需的结果数据。

The company currently operates across major health system partners nationwide, including Sentara, OrthoVirginia, WellSpan, Ochsner, Campbell Clinic, Gundersen, MultiCare, and St. Francis, spanning academic medical centers, health systems, and specialty orthopedic groups.

该公司目前在全国范围内与主要的卫生系统合作伙伴开展业务，包括森塔拉、弗吉尼亚骨科、威尔斯潘、奥克斯纳、坎贝尔诊所、甘德森、多护理和圣弗朗西斯，涵盖学术医疗中心、卫生系统和专业的骨科团体。

'We built Remission Medical around a simple but powerful premise: health systems already have the infrastructure, the patients, and the payer relationships - what they are missing is the specialty clinical capacity and the operational backbone to run it,' said Blake Wehman, Founder and Chief Executive Officer of Remission Medical.

“我们创建Remission Medical的初衷简单而有力：医疗系统已经具备了基础设施、患者和支付方关系——他们所缺少的是专业的临床能力和运营支持，”Remission Medical创始人兼首席执行官Blake Wehman表示。

'RemissionOS is what makes our model scalable. It allows us to bring a new health system partner live quickly, manage a distributed workforce with precision, and generate the performance data that keeps these programs growing. Rheumatology is where we've proven it. This investment opens the door to doing the same thing in other underserved specialties.'.

“RemissionOS 是我们模型可扩展的关键。它使我们能够快速让新的医疗系统合作伙伴上线，精确管理分布式劳动力，并生成推动这些项目持续增长的绩效数据。风湿病学是我们已经证明其价值的领域。这项投资为我们打开了在其他服务不足的专业领域做同样事情的大门。”

The Series A close follows a period of significant commercial traction, including triple-digit growth over multiple years and expansion into new geographies across the company's health system partner network. Proceeds will be used to expand health system partnerships, recruit and onboard clinical staff, and invest in ROS platform capabilities that support additional specialty offerings beyond rheumatology..

A轮融资的完成是在一段显著的商业吸引力时期之后，包括多年来的三位数增长，以及在公司健康系统合作伙伴网络中扩展到新的地理区域。所得款项将用于扩大健康系统合作伙伴关系，招募和培训临床工作人员，并投资于ROS平台的能力，以支持风湿病学以外的更多专科服务。

'What makes Remission Medical distinctive is the combination of a proven health system partnership model and a purpose-built technology platform that makes that model defensible at scale,' said Tom Benedetti, Partner at Blue Heron Capital. 'RemissionOS is not an afterthought – it is the operational engine that allows this team to grow the network without sacrificing quality or margin.

“Remission Medical 的独特之处在于其经过验证的健康系统合作伙伴模式与专为规模化运营打造的技术平台的结合，这使得该模式在大规模下仍具有可防御性，”蓝鹭资本合伙人 Tom Benedetti 表示。“RemissionOS 并非事后想法——它是使这个团队能够在不牺牲质量或利润的情况下扩展网络的运营引擎。”

We believe Remission Medical is building the category-defining infrastructure for how health systems access specialty care, starting in rheumatology and with a clear pathway to adjacent specialties.'.

我们相信，Remission Medical正在构建健康系统获取专科护理的类别定义基础设施，首先从风湿病学开始，并有通往相邻专科的清晰路径。

Looking ahead, Remission Medical sees its AI-native platform and health system partnership model as a blueprint extensible well beyond rheumatology. The operational infrastructure built into ROS, including workforce deployment, credentialing workflows, and multi-system revenue cycle automation, is designed to support expansion into other high-demand specialty areas where health systems face similar access shortfalls.

展望未来，Remission Medical 将其原生人工智能平台和健康系统合作伙伴模式视为可扩展到风湿病学领域之外的蓝图。ROS 中内置的操作基础设施，包括劳动力部署、认证工作流程和多系统收入周期自动化，旨在支持扩展到其他高需求专科领域，这些领域同样面临健康系统接入不足的问题。

The company expects to announce initial steps into adjacent specialties in the coming months..

公司预计将在未来几个月宣布进军相邻专业的初步步骤。

Remission Medical was founded by Blake Wehman, who brings both an operations research background and a personal connection to the company's mission, having managed a rheumatic condition himself. The company is headquartered in Henrico, Virginia.

Remission Medical 由布莱克·韦曼创立，他不仅拥有运筹学背景，还因自身曾患风湿病而与公司的使命有着个人联系。公司总部位于弗吉尼亚州的亨里科。

About Remission Medical

关于缓解医疗

Remission Medical is a national virtual rheumatology platform addressing the full range of rheumatological conditions, including rheumatoid arthritis, osteoporosis, osteoarthritis, lupus, and gout, among others. Remission Medical's providers include state-licensed, board-certified rheumatologists, physician assistants, and nurse practitioners with deep expertise in autoimmune inflammatory conditions.

Remission Medical 是一个全国性的虚拟风湿病学平台，涵盖各种风湿病状况，包括类风湿性关节炎、骨质疏松症、骨关节炎、红斑狼疮和痛风等。Remission Medical 的提供者包括持有州执照、经委员会认证的风湿病学家、医师助理和拥有自身免疫炎症疾病深厚专业知识的执业护士。

Built from the ground up for value-based care and value-based benefits, Remission partners with health systems, orthopedic practices, and other provider organizations with the goal of increasing access to much-needed rheumatology care for all patients. For more information, visit www.remissionmedical.com..

Remission 从零开始构建，专注于价值导向的医疗和价值导向的福利，与卫生系统、骨科诊所及其他医疗服务机构合作，旨在为所有患者增加获得急需的风湿病治疗的机会。欲了解更多信息，请访问 www.remissionmedical.com。

About Blue Heron Capital

关于蓝鹭资本

Blue Heron Capital is an early-stage growth equity firm funding big ideas in healthcare and enterprise technology. Leveraging a powerful combination of financial capital and the human capital of its OA Collaborative, Blue Heron partners with companies to build businesses that make big impacts. For additional information, please visit www.blueheroncap.com..

蓝鹭资本是一家早期成长型股权公司，为医疗保健和企业技术领域的大胆创意提供资金支持。通过结合金融资本与其OA协作团队的人力资本，蓝鹭与各公司合作打造具有重大影响力的企业。欲了解更多信息，请访问www.blueheroncap.com。